TO DETERMINE THE PREDICTIVE VALUE OF CARDIOVASCULAR RISK AND THE PREVALENCE OF PERIPHERAL ARTERIAL DISEASE IN HYPERTENSIVE PATIENTS BY THE PULSE WAVE VELOCITY METER VP PLUS 1000
Main Article Content
Abstract
Aim: To determine the predictive value of high cardiovascular risk of baPWV and the prevalence of peripheral arterial disease in hypertensive patients. Subjects and methods: 190 patients; 109 men, 81 women; mean age 61±17 years were diagnosed the primary hypertension alone or hypertension with diabetes. All were measured their extremity blood pressure by using the VP Plus 1000 pulse wave velocity meter. Left arm blood pressure was used to confirm the diagnosis and classify hypertension according to the ESH 2021. Diagnosis of peripheral arterial disease was based on the ABI index according to the recommendations of the ESC. Upper limb peripheral arterial disease was confirmed by subclavian angiography. Results: The right pulse wave velocity (baPWV) value in hypertensive patients with target blood pressure (normal blood pressure) was 1382.0 ± 211 cm/s; patients with slightly high cardiovascular risk were 1590.2 ± 173.6 cm/s; patients with high cardiovascular risk were: 2101.0 ± 563.4 cm/s and patients with suspected embolism were 2312.5 ± 949.5 cm/s; corresponding left pulse wave velocities were: 1423.3 ± 208.5 cm/s, 1586.5 ± 185.2, 2118.9 ± 586.6 cm/s, 2304.3 ± 983.4 cm/s. The cutoff value for predicting high cardiovascular risk of right baPWV was 1739 cm/s, left baPWV was 1762 cm/s. The rate of peripheral arterial disease in hypertensive patients with and without diabetes was 27.4%. Conclusion: Brachial-ankle pulse wave velocity (baPWV) increases gradually with the level of cardiovascular risk. Pulse wave velocity has a good predictive value for high cardiovascular risk with high sensitivity and specificity. Over quarter hypertensive patients had the peripherial arterial disease, the diabetes caused incresing its prevalence.
Article Details
References
2. GBD (2023), Global burden of periphery artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet Glob Health 2023.
3. Victor Aboyans et al (2017), 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery, European Heart Journal (2018) 39, 763-821.
4. Seung Jae Lee, et al. (2019), ”Relationship Between Brachial‐Ankle Pulse Wave Velocity and Incident Hypertension According to 2017 ACC/AHA High Blood Pressure Guidelines”
5. J S Gao et al (2016), Normal value and and reference value range of brachial-ankle pulse wave velocity among Kailuan study population, Pubmed, doi:10.3760/cma.j.isn 0253-3758.
6. Guoxiang Fu et al (2021), Diference Sensibility of Branchial - Ankle Pulse Wave Velocity and Ankle-Branchial Index for Cardiovascular Risk Assessement in Elderly Chinese: A Cross-Sectional Study, Artery Research, vol 27(2): June 2021, pp 82-86.
7. Hirofumi et al (2020), State of the Art Review: Brachial-Ankle PWV, The Official Journal of the Japan Althecrocler Thromb, 2020, 27:621-636.
8. Hack - Lyoung Kim et al (2023), Pronostic Value of Brachial-Ankle Pulse Wave Velocity According to Subjects’ Clinical Charcateristics:Data From Analysis of 10,597 Subjects, J Korean Med Sci, 2023, Dec 2538(50) e414.